Minocycline-induced liver injury

American Journal of Gastroenterology

Volumn 91, Issue 8, 1996, Pages 1641-1643

  Malcolm, Allison ^a,b   Heap, Timothy R ^a   Eckstein, Robert P ^a   Lunzer, Michael R ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; DOUBLE STRANDED DNA; MINOCYCLINE; MULTIVITAMIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ACNE; ADOLESCENT; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; EPIGASTRIC PAIN; FATIGUE; FATTY LIVER; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLESTASIS; LIVER INJURY; LIVER TOXICITY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RASH; VASCULITIS;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BIOPSY; FEMALE; HEPATITIS, CHRONIC, DRUG-INDUCED; HEPATITIS, TOXIC; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MINOCYCLINE;

EID: 0029737720     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lepper MH, Wolfe CK, Zimmerman H, et al. Effects of large doses of Aureomycin on human liver. Arch Intern Med 1951;88:271-83.
2. Dowling HF, Lepper MH. Hepatic reactions to tetracycline. JAMA 1964;188:307-9.
3. Schultz JC, Adamson JS, Workman WW, et al. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963;269:999-1004.
4. Hunt CM, Washington K. Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology 1994;107:1844-7.
5. Freneaux E, Labbe G, Letteron P, et al. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in micro vesicular steatosis induced by this antibiotic. Hepatology 1988;8:1056-62.
6. Chatham WW, Ross DW. Leukemoid blood reaction to tetracycline. South Med J 1983;76:1195-6.
7. Burette A, Finet C, Prigogine T, et al. Acute hepatic injury associated with minocycline. Arch Intern Med 1984;144:1491-2.
8. Davies MG, Kersey JW. Acute hepatitis and exfoliative dermatitis associated with minocycline. Br Med J 1989;298:1523-4.
9. Min DI, Pharm D, Burke PA, et al. Acute hepatic failure associated with oral minocycline: A case report. Pharmacotherapy 1992;12:68-71.
10. Fagan E, Williams R. Identification of toga-like virus in fulminant hepatitis attributed to minocycline therapy. Br Med J 1989;299: 1224.
11. Sande MA, Mandell GL. Antimicrobial agents. Tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In: Goodman and Gilman's, The pharmacological basis of therapeutics, 7th ed. New York: Macmillan, 1985:1170-98.
12. Farrell GC. The clinicopathological spectrum of drug-induced liver diseases. In: Drug-induced liver disease. New York: Churchill Livingstone, 1994:101-13.
13. Matsuura T, Shimizu Y, Fujimoto H, et al. Minocycline-related lupus. Lancet 1992;340:1553 (letter).
14. Malcolm A, Heap TR, Lunzer ML, et al. Minocycline-induced liver injury. Hepatology 1995;22:A1383.
15. Gough A, Chapman S, Wagstaff K, et al. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996;312:169-72.
16. Birkett DJ, Mitchell AS, Godeck A, et al. Profiles of antibacterial drug use in Australia and trends from 1987 to 1989. Med J Aust 1991;155:410-5.